APRIL 2017 Deal Watch Review now published.
Roger Davies works with Medius as a consultant in pharmaceutical licensing and business development. Having personally completed more than 100 deals he specialises in valuations, deal structuring and negotiating licensing and acquisition deals.
He is the former Chairman of the UK Pharmaceutical Licensing Group, the professional association of licensing and business development executives and is the Finance module leader for the Business Development MSc at the University of Manchester.
Roger was formerly the Group Director of Licensing and Business Development at Bioglan Pharma Plc where he was responsible for the global licensing and acquisition of products and drug delivery technologies as well as European distributors and the Legal department. Prior to joining Bioglan in 2000, Roger was employed at Mundipharma International for 10 years as Director of International Business Development where he was responsible for product and company acquisitions/disposals, inward and outward product licensing.
Roger’s other industry experience includes Fisons Pharmaceuticals and Rank Xerox in a variety of roles in business development, finance, strategic planning and marketing. Roger has a Masters degree in Economics.